Delivery Order SPE2DB22D2005-SPE2DB25FJTD5
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,334.98 by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30s. The contract is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and was competitively awarded with no set-aside designation. This award represents a child contract under AmerisourceBergen's broader relationship...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 30, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose) valued at $11,415.23. This firm fixed-price contract award was competitively procured with no set-aside designation and carries an ultimate completion date of July 31, 2025. The delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $70,700.93 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. The contract represents a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, the company's corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 29, 2025, by the Defense Logistics Agency (DLA) for the supply of RINVOQ ER 45 MG tablets (28-count units). The contract, valued at $60,445.18, is structured as a firm fixed price delivery order with an ultimate completion date of September 2, 2025. This award represents a non-set-aside, competitively awarded procurement and is issued as a child order under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $274,266.46 by the Defense Logistics Agency's Medical Supply Chain to supply RINVOQ ER 45 mg tablets in a quantity of 28 units. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a Delivery Order contract by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of RINVOQ ER 15 MG tablets in quantities of 30 units. This firm fixed price delivery order, valued at $11,576.19, represents a non-competitive award under DLA's pharmaceutical supply chain supporting federal medical procurement needs. The contract is scheduled for completion by August 6, 2025, with performance originating from AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract from the Defense Logistics Agency (DLA) on September 18, 2025, valued at $16,823.38 for RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 19, 2025. The award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,097.72 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) with an ultimate completion date of May 28, 2025. This non-set-aside, firm fixed price contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.70 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose packaging) with a contract value of $36,032.60. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that extends through...